# Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities

> **NCT04584892** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 18 (actual)

## Conditions studied

- Haemophilia A

## Interventions

- **DRUG:** Turoctocog alfa

## Key facts

- **NCT ID:** NCT04584892
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-04-12
- **Primary completion:** 2023-03-27
- **Final completion:** 2023-03-27
- **Target enrollment:** 18 (ACTUAL)
- **Last updated:** 2023-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04584892

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04584892, "Turoctocog Alfa in Haemophilic Italian Patients: Protection and Engagement in Recreational Activities". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04584892. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*